A unified effort to help our island of partners as well as our ust partners to achieve their response and recovery goals, starting with the eyelids the goal to stabilize the Virgin Islands and puerto rico to make sure we are addressing all lifes safety and lifesustaining issues and we are in good position. Theres great communication with both governors in the Island Community and the objectives are clear, emergency, power restored power, life saving and lifesustaining commodities, emergency can medication and security. Those are the goals we are supporting and this is a massive effort because of logistical nature of accessing islands, we are very proud to have our partners with the department of defense. They have the provided over six different navys ships in the area that will operate today to help us accomplish helped our island partners, which their goals. Moving on, obviously Hurricane Irma continues to be a threat to devastate the us, either florida or some southeastern states. T
Democrats call 202 7488000. Republicans call 202 7488001. Independents and others 202 7488002. We welcome your comments on our Facebook Page and will look for your tweets as well. Just a quick note on the hurricane, we are expecting a briefing sometime in the half fema and0 or so, from will take you to that when it comes up. We will talk to a florida congressman within the hour. Were talking about the president s deal with democrats. The storm this morning downgraded to category four, churning through the caribbean on its way to florida. The news about the hurricane making the front page of newspapers across the country. As is the deal that has been reached with Congressional Democrats and President Trump. The headline this morning from the Washington Times, bipartisan deal seen as a new era for President Trump. President trump wons first bipartisan legislative victory thursday as the debt spending deal approved. Democratic leaders, he writes, vowed to resist the president , now they c
The way theyre seated but first, a senior fellow for middle east policy who has written excellent analyses of the situation in syria and iraq as well as within islam. If youre not familiar with the analysis preceding the civil war which identified the ground war for possible sectarian conflict in syria, it was really an impression analysis and he remains one of the best analysis of the situation that i know of. Kristin is the president and ceo of the organization and has had a long productive career. I should add they both are members of our task force. Finally, Katherine Zimmerman from the critical threats project at the American Enterprise institute, her article is an excellent read. Finally, as our moderator we are pleased to have kim barker from the New York Times who has tremendous experience reporting from afghanistan and pakistan and whose excellent book i also recommend to all of you on the taliban shuffle, strange days in afghanistan and pakistan. Thank you for having us here
The Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for their efforts throughout the negotiation process. And for offering their insight to the committee. Both the energy and Commerce Health subcommittee and full committee have a strong record of by partisan ship on Public Health issues. Such as cures. The fda reauthorizization act and i hope to add to the record of success with todays hearing. Over the counter drug products treat a wide variety of ailments. Time and again consumers se
Public discussion on modernizing the Current System at the United States food and Drug Administration to review, approve and update over the counter drugs. This hearing provides us and the American Public with an opportunity to better understand the food and Drug Administration regulatory pram work to regulate over the counter drugs and consider a proposal to reform the monograph system. Today we will convene two panels of witnesses. First i want to welcome dr. Woodcock back to the subcommittee this morning. Later well hear from representatives of other key stake holders. And commend all for their efforts throughout the negotiation process. And for offering their insight to the committee. Both the energy and Commerce Health subcommittee and full committee have a strong record of by partisan ship on Public Health issues. Such as cures. The fda reauthorizization act and i hope to add to the record of success with todays hearing. Over the counter drug products treat a wide variety of ailm